> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# J&J’s Cerenovus Recalls Neurovascular Coil Devices
- URL: https://www.fdaweb.com/j-js-cerenovus-recalls-neurovascular-coil-devices/
- Published: 2026-02-05T12:00:00.000Z
- Updated: 2026-09-14T15:32:36.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5160619

Johnson & Johnson MedTech has recalled (Class 1) multiple versions of its Cerepak Detachable Coil System, which is manufactured by subsidiary Cerenovus, for treating intracranial aneurysms and other neurovascular conditions. An FDA [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/detachable-coil-system-recall-jj-medtechcerenovus-inc-remove-cerepak-detachable-coil-system?utm%5Fmedium=email&utm%5Fsource=govdelivery) says the devices are being removed from hospitals and other points of use after the manufacturer identified a higher-than-expected rate of failure during deployment. Such failures can lead to hemorrhagic or ischemic stroke, prolonged procedures, or the need for additional surgical intervention. As of 10/2025, J&J MedTech had reported four serious injuries and one death associated with the issue, it says.

The Cerepak coil systems are indicated for embolization procedures used to treat intracranial aneurysms, arteriovenous malformations and fistulae, and certain peripheral vascular conditions.